IntroductionMost patients with HPV-positive oropharyngeal squamous cell carcinoma (OPSCC) have an excellent response to chemoradiation. and trials are now investigating de-escalated treatment. However. up to 25% of patients with HPV-positive OPSCC will experience recurrence. https://www.marcelovicente.com/product-category/bouncy-spray-curl-activator/